Thomas Perpoint

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

Florence Ader, Maude Bouscambert‐Duchamp, Maya Hites et al. · The Lancet Infectious Diseases · 2021 · 338 citations · Full text

Type I IFN immunoprofiling in COVID-19 patients

Sophie Trouillet‐Assant, Sébastien Viel, Alexandre Gaymard et al. · Journal of Allergy and Clinical Immunology · 2020 · 273 citations · Full text

Immunology, Immunologic Disease, Covid-19 Patients +2

Virulence determinants in Staphylococcus aureus and their involvement in clinical syndromes

Tristan Ferry, Thomas Perpoint, François Vandenesch et al. · Current Infectious Disease Reports · 2005 · 91 citations

Pathogenic Microbiology, Virulence Factor, Pathogenesis +11

Innovations for the treatment of a complex bone and joint infection due to XDR Pseudomonas aeruginosa including local application of a selected cocktail of bacteriophages

Tristan Ferry, Fabien Boucher, Cindy Fèvre et al. · Journal of Antimicrobial Chemotherapy · 2018 · 90 citations · Full text

Neurological manifestations of COVID-19 in adults and children

Sung‐Min Cho, Nicole White, Lavienraj Premraj et al. · Brain · 2022 · 83 citations · Full text

Virus Epidemiology, Covid-19 Epidemiology, Covid-19 +21